impact factor
logo
 

Full Papers

 

Prevalence of fibromyalgia and associated factors in Spain


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17

 

  1. Rheumatology, Hospital Comarcal de Inca, Baleares, Spain.
  2. Rheumatology, Hospital Comarcal de Inca, Baleares, Spain.
  3. Rheumatology, Hospital Son Llàtzer, Palma de Mallorca, Baleares, Spain. ajuan69@gmail.com
  4. Research Unit, Spanish Society of Rheumatology, Madrid, Spain.
  5. Rheumatology, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
  6. Rheumatology, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
  7. Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  8. Rheumatology, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain.
  9. Rheumatology, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain.
  10. Rheumatology, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain.
  11. Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
  12. Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
  13. Rheumatology, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain.
  14. Rheumatology, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain.
  15. Research Unit, Spanish Society of Rheumatology, Madrid, Spain.
  16. Rheumatology, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife; and Universidad de La Laguna, Departamento de Medicina Interna, Dermatología y Psiquiatría, La Laguna, Santa Cruz de Tenerife, Spain.
  17. Rheumatology, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.

on behalf of the Working Group Proyecto EPISER2016

CER12497
2020 Vol.38, N°1 ,Suppl.123
PI 0047, PF 0052
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 31928589 [PubMed]

Received: 11/06/2019
Accepted : 14/10/2019
In Press: 08/01/2020
Published: 21/02/2020

Abstract

OBJECTIVES:
The prevalence of fibromyalgia (FM) differs depending on the population studied. The main objective of the EPISER2016 study was to estimate the prevalence of FM in adults in Spain. The secondary objective was to evaluate the association with sociodemographic and anthropometric characteristics and smoking.
METHODS:
This is a population-based cross-sectional multicentre study. The random selection was based on multistage stratified cluster sampling. The final sample comprised 4916 persons aged ≥20 years. Participants were contacted by telephone for completion of a screening survey. Investigating rheumatologists evaluated positive results (review of medical records and/or telephone interview, with medical visit if needed) to confirm the diagnosis. Prevalence and 95% confidence interval were calculated, taking into account the sample design. Weighing was applied based on age, sex, and geographic origin. Predictive models were constructed to analyse which sociodemographic, anthropometric and lifestyle variables in the call centre questionnaire were associated with the presence of FM.
RESULTS:
602 subjects (12.25%) had a positive screening result for FM, of which 24 were missing (3.99%). A total of 141 cases of FM were recorded. The estimated prevalence was 2.45% (95% CI, 2.06-2.90). Female sex was the variable most associated with FM, with an odds ratio (OR) of 10.156 (95% CI, 5.068-20.352). Peak prevalence was at 60-69 years (p=0.009, OR=6.962). FM was 68% more frequent in obese individuals (OR, 1.689; 95% CI, 1.036-2.755).
CONCLUSIONS:
The prevalence of FM in adults in Spain barely changed between 2000 and 2016 and it is similar to that observed in Europe as a whole.

Rheumatology Article

Rheumatology Addendum